Damaj Bassam 4
4 · INNOVUS PHARMACEUTICALS, INC. · Filed Feb 5, 2013
Insider Transaction Report
Form 4
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2013-02-02$0.48/sh+250,406$118,993→ 250,406 total
Footnotes (1)
- [F1]Private, non-market transaction.